A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as Add-On Therapy in Adult Subjects with Epilepsy Consisting of Uncontrolled Partial-Onset Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date10/3/07 → 9/30/10

Funding

  • Pharmaceutical Research Associates: $87,898.00